DK1129186T3 - Et faktor VIII-polypeptid med faktor VIII:C-aktivitet - Google Patents

Et faktor VIII-polypeptid med faktor VIII:C-aktivitet

Info

Publication number
DK1129186T3
DK1129186T3 DK99953425T DK99953425T DK1129186T3 DK 1129186 T3 DK1129186 T3 DK 1129186T3 DK 99953425 T DK99953425 T DK 99953425T DK 99953425 T DK99953425 T DK 99953425T DK 1129186 T3 DK1129186 T3 DK 1129186T3
Authority
DK
Denmark
Prior art keywords
factor viii
activity
polypeptide
fviii
domains
Prior art date
Application number
DK99953425T
Other languages
English (en)
Other versions
DK1129186T4 (da
Inventor
Koenraad Mertens
Peter Turecek
Hans-Peter Schwarz
Friedrich Scheiflinger
Petrus Johannes Lenting
Mourik Jan Aart Van
Hans Pannekoek
Original Assignee
Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3522842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1129186(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanquin Bloedvoorziening filed Critical Sanquin Bloedvoorziening
Publication of DK1129186T3 publication Critical patent/DK1129186T3/da
Application granted granted Critical
Publication of DK1129186T4 publication Critical patent/DK1129186T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK99953425.8T 1998-11-10 1999-11-10 Et faktor VIII-polypeptid med faktor VIII:C-aktivitet DK1129186T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT187298 1998-11-10
PCT/AT1999/000272 WO2000028021A1 (de) 1998-11-10 1999-11-10 Ein faktor viii-polypeptid mit faktor viii:c-aktivität

Publications (2)

Publication Number Publication Date
DK1129186T3 true DK1129186T3 (da) 2008-01-21
DK1129186T4 DK1129186T4 (da) 2017-02-06

Family

ID=3522842

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99953425.8T DK1129186T4 (da) 1998-11-10 1999-11-10 Et faktor VIII-polypeptid med faktor VIII:C-aktivitet

Country Status (11)

Country Link
US (3) US6919311B2 (da)
EP (1) EP1129186B2 (da)
AT (1) ATE372382T1 (da)
AU (2) AU775529B2 (da)
CA (1) CA2349468C (da)
CY (1) CY1107821T1 (da)
DE (1) DE59914490D1 (da)
DK (1) DK1129186T4 (da)
ES (1) ES2292255T5 (da)
PT (1) PT1129186E (da)
WO (1) WO2000028021A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1129186T4 (da) * 1998-11-10 2017-02-06 Stichting Sanquin Bloedvoorziening Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
WO2000071714A2 (en) * 1999-05-24 2000-11-30 The American National Red Cross Methods of reducing factor viii clearance and compositions therefor
EP1351986A2 (en) 2001-01-12 2003-10-15 The American National Red Cross Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
WO2003093313A2 (en) * 2002-04-29 2003-11-13 Baxter International Inc. Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
US20050026823A1 (en) 2003-06-20 2005-02-03 Biomarin Pharmaceutical Inc. Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
US7211559B2 (en) 2003-10-31 2007-05-01 University Of Maryland, Baltimore Factor VIII compositions and methods
KR101468345B1 (ko) 2004-11-12 2014-12-03 바이엘 헬스케어 엘엘씨 Ｆｖｉｉｉ의 부위 지향 변형
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
FR2913020B1 (fr) * 2007-02-23 2012-11-23 Biomethodes Nouveaux facteurs viii pour le traitement des hemophiles de type a
EP1985631A1 (en) * 2007-04-20 2008-10-29 LFB Biotechnologies Demannosylated recombinant factor VIII for the treatment of patients with hemophiila A
CN108530543B (zh) 2009-02-03 2023-06-23 阿穆尼克斯制药公司 延伸重组多肽和包含该延伸重组多肽的组合物
CN102741275B (zh) 2009-08-24 2016-08-03 阿穆尼克斯运营公司 凝血因子ix组合物及其制备和使用方法
KR101808751B1 (ko) 2009-11-13 2017-12-13 그리폴스 테라퓨틱스 인코포레이티드 폰 빌레브란트 인자(ｖＷＦ)-함유 제제, 및 그와 관련된 방법, 키트 및 용도
JP6042335B2 (ja) 2010-09-15 2016-12-14 ノヴォ ノルディスク アー／エス 細胞取込みが低下した第ｖｉｉｉ因子変異体
EA032336B1 (ru) 2010-09-17 2019-05-31 Баксалта Инкорпорейтид Стабильная водная иммуноглобулиновая композиция и способ стабилизации иммуноглобулиновой композиции
BRPI1105317A2 (pt) * 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1
LT3564260T (lt) 2012-02-15 2023-01-10 Bioverativ Therapeutics Inc. Viii faktoriaus kompozicijos ir jų gamybos bei panaudojimo būdai
EP2822577B1 (en) 2012-02-15 2019-02-06 Bioverativ Therapeutics Inc. Recombinant factor viii proteins
TWI667255B (zh) 2013-08-14 2019-08-01 美商生物化學醫療公司 因子ｖｉｉｉ－ｘｔｅｎ融合物及其用途
EP3069141A4 (en) * 2013-11-15 2017-05-10 President and Fellows of Harvard College Methods and assays for factor viii activity
SG11201605242YA (en) 2014-01-10 2016-07-28 Biogen Ma Inc Factor viii chimeric proteins and uses thereof
EP3114138B1 (en) 2014-03-05 2021-11-17 Pfizer Inc. Improved muteins of clotting factor viii
ES2841437T3 (es) 2015-04-13 2021-07-08 Inst Nat Sante Rech Med Métodos y composiciones farmacéuticas para el tratamiento de enfermedades hemorrágicas
IL257231B (en) 2015-08-03 2022-09-01 Bioverativ Therapeutics Inc Factor ix fusion proteins and methods of making and using same
MX2018006738A (es) 2015-12-03 2018-09-21 Baxalta Inc Factor viii con propiedades de semivida extendida y union reducida al ligando.
MX2019006444A (es) 2016-12-02 2019-10-30 Bioverativ Therapeutics Inc Métodos de tratamiento de artropatía hemofílica utilizando factores de coagulación quiméricos.
SI3793588T1 (sl) 2018-05-18 2025-07-31 Bioverativ Therapeutics Inc. Postopki zdravljenja hemofilije A

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451521A (en) * 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US5364771A (en) † 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
WO1997003195A1 (en) * 1995-07-11 1997-01-30 Chiron Corporation Novel factor viii:c polypeptide analogs with altered protease sites
AT403438B (de) 1996-05-24 1998-02-25 Immuno Ag Pharmazeutische präparation mit faktor viii prokoagulationsaktivität und vwf-bindungsaktivität
DK1129186T4 (da) * 1998-11-10 2017-02-06 Stichting Sanquin Bloedvoorziening Et faktor VIII-polypeptid med faktor VIII:C-aktivitet

Also Published As

Publication number Publication date
EP1129186B2 (de) 2016-11-30
US6919311B2 (en) 2005-07-19
EP1129186A1 (de) 2001-09-05
DK1129186T4 (da) 2017-02-06
US20050074836A1 (en) 2005-04-07
EP1129186B1 (de) 2007-09-05
AU775529B2 (en) 2004-08-05
CY1107821T1 (el) 2013-06-19
CA2349468C (en) 2013-07-09
US8546332B2 (en) 2013-10-01
AU2004222822B2 (en) 2007-01-25
CA2349468A1 (en) 2000-05-18
ES2292255T3 (es) 2008-03-01
DE59914490D1 (de) 2007-10-18
US20110118188A1 (en) 2011-05-19
ATE372382T1 (de) 2007-09-15
WO2000028021A1 (de) 2000-05-18
US20060160994A1 (en) 2006-07-20
AU1018500A (en) 2000-05-29
US7544660B2 (en) 2009-06-09
PT1129186E (pt) 2007-12-07
AU2004222822A1 (en) 2004-11-18
ES2292255T5 (es) 2017-05-19

Similar Documents

Publication Publication Date Title
DE59914490D1 (de) Ein faktor viii-polypeptid mit faktor viii:c-aktivität
NO964650L (no) LAG-3 proteinopploselige polypeptidfraksjoner, fremgangsmate for fremstilling, terapeutisk preparat og anti-idiotype antistoff
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
PT1137941E (pt) Esqueletos de proteínas para compostos miméticos de anticorpos e outras proteínas de ligação
DE69520088D1 (de) Interferon-gamma-induzierendes Polypeptid monoklonal Antikörper, und Zusammensetzung für Interferon-gamma gebunden Krankheiten
HRP20000714B1 (en) NOVEL CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
DE69534588D1 (de) Protocadherin-proteine und verwendungen davon
US5043429B1 (en) Protein fragments containing factor VIII binding domain of von willebrand factor
DK0503648T3 (da) CD2-bindingsdomæne af lymfocytfunktion-associeret antigen 3
ATE328896T1 (de) Faktor viii vom schwein und hybriden
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
FI954805A7 (fi) Menetelmiä insuliininkaltaisen kasvutekijän sitojaproteiinien käyttämi seksi
DE69737651D1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
FI972384A7 (fi) Uudet dipeptidiset p-amidinobentsyyliamidit, jotka sisältävät N-termin aalisia sulfonyyli- tai amidinosulfonyyliryhmiä
TW272197B (da)
ATE225806T1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
ATE356831T1 (de) Neuer galaninrezeptor
DE3852293D1 (de) Verfahren und struktur zur justierung von reflektorflächen.
FI943218A7 (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja k äytöt
EP0588036A3 (en) Composition for the isolation of apamine receptor, apamine binding protein and its uses.
FI891652A7 (fi) Menetelmä proteiinien valmistamiseksi, joiden N-terminaali alkaa proliinilla
ATA110696A (de) Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E